Cencora ROA 2010-2025 | COR
Current and historical return on assets (ROA) values for Cencora (COR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Cencora ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-06-30 | $1.90B | $73.96B | 2.70% |
| 2025-03-31 | $1.69B | $71.19B | 2.47% |
| 2024-12-31 | $1.40B | $69.05B | 2.09% |
| 2024-09-30 | $1.51B | $67.10B | 2.30% |
| 2024-06-30 | $1.86B | $66.77B | 2.88% |
| 2024-03-31 | $1.85B | $63.87B | 2.94% |
| 2023-12-31 | $1.87B | $64.69B | 3.02% |
| 2023-09-30 | $1.75B | $62.56B | 2.91% |
| 2023-06-30 | $1.69B | $61.18B | 2.88% |
| 2023-03-31 | $1.62B | $58.77B | 2.81% |
| 2022-12-31 | $1.73B | $57.91B | 3.02% |
| 2022-09-30 | $1.70B | $56.56B | 2.97% |
| 2022-06-30 | $1.84B | $57.17B | 3.21% |
| 2022-03-31 | $1.73B | $57.31B | 3.03% |
| 2021-12-31 | $1.61B | $57.58B | 2.96% |
| 2021-09-30 | $1.54B | $57.34B | 2.99% |
| 2021-06-30 | $-3.74B | $55.93B | -7.76% |
| 2021-03-31 | $-3.75B | $47.00B | -8.42% |
| 2020-12-31 | $-3.22B | $45.85B | -7.45% |
| 2020-09-30 | $-3.41B | $44.28B | -8.16% |
| 2020-06-30 | $1.57B | $40.79B | 3.88% |
| 2020-03-31 | $1.58B | $42.04B | 3.96% |
| 2019-12-31 | $0.65B | $40.02B | 1.66% |
| 2019-09-30 | $0.86B | $39.17B | 2.20% |
| 2019-06-30 | $0.96B | $38.48B | 2.48% |
| 2019-03-31 | $0.93B | $38.81B | 2.41% |
| 2018-12-31 | $1.19B | $39.27B | 3.10% |
| 2018-09-30 | $1.66B | $37.67B | 4.40% |
| 2018-06-30 | $1.08B | $38.31B | 2.91% |
| 2018-03-31 | $0.85B | $38.40B | 2.36% |
| 2017-12-31 | $0.98B | $36.36B | 2.78% |
| 2017-09-30 | $0.36B | $35.32B | 1.05% |
| 2017-06-30 | $0.85B | $34.65B | 2.50% |
| 2017-03-31 | $1.15B | $34.40B | 3.45% |
| 2016-12-31 | $1.35B | $33.92B | 4.08% |
| 2016-09-30 | $1.43B | $33.64B | 4.43% |
| 2016-06-30 | $1.64B | $31.91B | 5.34% |
| 2016-03-31 | $1.51B | $32.50B | 5.09% |
| 2015-12-31 | $0.39B | $30.76B | 1.39% |
| 2015-09-30 | $-0.14B | $27.96B | -0.51% |
| 2015-06-30 | $-0.43B | $27.33B | -1.72% |
| 2015-03-31 | $-0.66B | $27.01B | -2.81% |
| 2014-12-31 | $0.03B | $24.91B | 0.15% |
| 2014-09-30 | $0.27B | $21.53B | 1.33% |
| 2014-06-30 | $0.26B | $20.63B | 1.30% |
| 2014-03-31 | $0.44B | $20.36B | 2.33% |
| 2013-12-31 | $0.31B | $19.80B | 1.71% |
| 2013-09-30 | $0.43B | $18.92B | 2.59% |
| 2013-06-30 | $0.55B | $16.58B | 3.43% |
| 2013-03-31 | $0.56B | $16.11B | 3.56% |
| 2012-12-31 | $0.73B | $15.50B | 4.65% |
| 2012-09-30 | $0.72B | $15.44B | 4.57% |
| 2012-06-30 | $0.70B | $15.75B | 4.50% |
| 2012-03-31 | $0.71B | $15.65B | 4.59% |
| 2011-12-31 | $0.71B | $15.98B | 4.67% |
| 2011-09-30 | $0.71B | $14.98B | 4.81% |
| 2011-06-30 | $0.70B | $14.86B | 4.82% |
| 2011-03-31 | $0.68B | $14.68B | 4.74% |
| 2010-12-31 | $0.65B | $14.13B | 4.58% |
| 2010-09-30 | $0.64B | $14.44B | 4.56% |
| 2010-06-30 | $0.63B | $14.00B | 4.55% |
| 2010-03-31 | $0.58B | $13.82B | 4.33% |
| 2009-12-31 | $0.54B | $13.56B | 4.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.166B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.686B | 27.39 |
| CVS Health (CVS) | United States | $90.749B | 11.28 |
| Elevance Health (ELV) | United States | $69.812B | 9.39 |
| DiDi Global (DIDIY) | China | $27.862B | 29.60 |
| Labcorp Holdings (LH) | United States | $23.139B | 18.39 |
| Natera (NTRA) | United States | $22.743B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.474B | 0.00 |
| ICON (ICLR) | Ireland | $13.871B | 13.35 |
| Medpace Holdings (MEDP) | United States | $13.184B | 34.89 |
| CochLear (CHEOY) | Australia | $12.924B | 0.00 |
| Solventum (SOLV) | United States | $12.643B | 13.05 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 18.66 |
| Avantor (AVTR) | United States | $9.067B | 13.30 |
| Charles River Laboratories (CRL) | United States | $8.057B | 15.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.725B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.112B | 34.38 |
| Sotera Health (SHC) | United States | $4.658B | 26.03 |
| BrightSpring Health Services (BTSG) | United States | $4.246B | 32.39 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.627B | 83.06 |
| Alignment Healthcare (ALHC) | United States | $3.105B | 0.00 |
| KindlyMD (NAKA) | United States | $3.035B | 0.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.358B | 2.57 |
| Premier (PINC) | United States | $2.129B | 19.74 |
| Progyny (PGNY) | United States | $1.947B | 41.16 |
| Ardent Health (ARDT) | United States | $1.793B | 6.92 |
| PACS (PACS) | United States | $1.777B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.504B | 25.47 |
| Pediatrix Medical (MD) | United States | $1.483B | 9.90 |
| Teladoc Health (TDOC) | United States | $1.380B | 0.00 |
| Omada Health (OMDA) | $1.246B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.210B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.831B | 4.87 |
| AMN Healthcare Services Inc (AMN) | United States | $0.780B | 9.64 |
| CareDx (CDNA) | United States | $0.682B | 12.56 |
| Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Nutex Health (NUTX) | United States | $0.500B | 7.57 |
| Sonida Senior Living (SNDA) | United States | $0.495B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.493B | 84.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.457B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.455B | 6.83 |
| So-Young (SY) | China | $0.433B | 0.00 |
| SBC Medicals (SBC) | United States | $0.426B | 9.32 |
| Enhabit (EHAB) | United States | $0.402B | 26.47 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.227B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.149B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.115B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |